Bir sonraki

Otomatik oynatma

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 Görünümler • 07/18/23
Pay
gömmek
administrator
administrator
Aboneler
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma